- Home
- WSFS vs VKTX Comparison
WSFS vs VKTX Comparison
Compare WSFS & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSFS | VKTX |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WSFS | VKTX |
|---|---|---|
| Price | $70.82 | $28.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $76.20 | ★ $95.86 |
| AVG Volume (30 Days) | 315.7K | ★ 2.2M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ 15.42 | N/A |
| EPS | ★ 1.64 | N/A |
| Revenue | ★ $963,949,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.40 | N/A |
| P/E Ratio | $42.88 | ★ N/A |
| Revenue Growth | ★ 50.18 | N/A |
| 52 Week Low | $49.92 | $22.96 |
| 52 Week High | $73.22 | $43.15 |
Technical Indicators
Market Signals| Indicator | WSFS | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.48 | 32.66 |
| Support Level | $65.60 | $25.77 |
| Resistance Level | $71.30 | $36.20 |
| Average True Range (ATR) | 1.42 | 1.59 |
| MACD | -0.36 | -0.29 |
| Stochastic Oscillator | 42.60 | 3.99 |
Price Performance
Historical ComparisonAbout WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: the WSFS Bank segment provides loans and leases, and other financial products to commercial and consumer customers; the Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and the Wealth and Trust segment provides a broad array of planning and advisory services, investment management, trust services, and credit and deposit products to individual, corporate, and institutional clients. The majority of revenue is generated from the WSFS Bank segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.